Medicare Part D Spending on Single-Enantiomer Drugs Versus Their Racemic Precursors

Ann Intern Med. 2019 Oct 1;171(7):521-523. doi: 10.7326/M19-1085. Epub 2019 Aug 13.
No abstract available

MeSH terms

  • Databases, Pharmaceutical
  • Humans
  • Medicare Part D / economics*
  • Prescription Drugs / economics*
  • Stereoisomerism*
  • United States

Substances

  • Prescription Drugs